How validated receptor occupancy flow cytometry assays can impact decisions and support drug development
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
How validated receptor occupancy flow cytometry assays can impact decisions and support drug development
Authors
Keywords
-
Journal
CYTOMETRY PART B-CLINICAL CYTOMETRY
Volume 90, Issue 2, Pages 150-158
Publisher
Wiley
Online
2015-09-03
DOI
10.1002/cyto.b.21320
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies
- (2014) J. Deckert et al. CLINICAL CANCER RESEARCH
- A Dose-Escalation Study of SAR3419, an Anti-CD19 Antibody Maytansinoid Conjugate, Administered by Intravenous Infusion Once Weekly in Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
- (2013) V. Ribrag et al. CLINICAL CANCER RESEARCH
- Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
- (2013) M Reilly et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CD38 and CD157: A long journey from activation markers to multifunctional molecules
- (2013) Valeria Quarona et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicin
- (2013) Roland Walter Frontiers in Bioscience-Landmark
- Comparison between Internalizing Anti-HER2 mAbs and Non-Internalizing Anti-CEA mAbs in Alpha-Radioimmunotherapy of Small Volume Peritoneal Carcinomatosis Using 212Pb
- (2013) Vincent Boudousq et al. PLoS One
- A phase Ib multiple ascending dose study evaluating safety, pharmacokinetics, and early clinical response of brodalumab, a human anti-IL-17R antibody, in methotrexate-resistant rheumatoid arthritis
- (2013) David A Martin et al. ARTHRITIS RESEARCH & THERAPY
- Correlation of CD33 expression level with disease characteristics and response to gemtuzumab ozogamicin containing chemotherapy in childhood AML
- (2012) J. A. Pollard et al. BLOOD
- A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma
- (2012) William Bensinger et al. BRITISH JOURNAL OF HAEMATOLOGY
- A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: Proof of principle with rituximab and ofatumumab
- (2012) Patrick J. Engelberts et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Impact of Epidermal Growth Factor Receptor (EGFR) Cell Surface Expression Levels on Effector Mechanisms of EGFR Antibodies
- (2012) S. Derer et al. JOURNAL OF IMMUNOLOGY
- Tumor penetration and epidermal growth factor receptor saturation by panitumumab correlate with antitumor activity in a preclinical model of human cancer
- (2012) Daniel J Freeman et al. Molecular Cancer
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Phase I studies of AVE9633, an anti-CD33 antibody-maytansinoid conjugate, in adult patients with relapsed/refractory acute myeloid leukemia
- (2011) Simona Lapusan et al. INVESTIGATIONAL NEW DRUGS
- MTRX1011A, a humanized anti-CD4 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: a Phase I randomized, double-blind, placebo-controlled study incorporating pharmacodynamic biomarker assessments
- (2011) Heleen Scheerens et al. ARTHRITIS RESEARCH & THERAPY
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Recommendations for the validation of flow cytometric testing during drug development: I instrumentation
- (2010) Cherie L. Green et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy
- (2010) Sylvine Cottin et al. Molecular Cancer
- Development and validation of flow cytometry methods for pharmacodynamic clinical biomarkers
- (2010) Dianna Y Wu et al. Bioanalysis
- Tumor Delivery and In Vivo Processing of Disulfide-Linked and Thioether-Linked Antibody−Maytansinoid Conjugates
- (2009) Hans K. Erickson et al. BIOCONJUGATE CHEMISTRY
- Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
- (2009) J. C. Byrd et al. BLOOD
- Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor 1
- (2009) Anthony W. Tolcher et al. JOURNAL OF CLINICAL ONCOLOGY
- Federal Task Force Seeks Standards for Immunotherapy Biomarker Studies
- (2009) Joel B. Finkelstein JNCI-Journal of the National Cancer Institute
- An Approach to the Validation of Flow Cytometry Methods
- (2009) Jo Cunliffe et al. PHARMACEUTICAL RESEARCH
- Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse
- (2008) P. Munoz et al. BLOOD
- Approximations of the target-mediated drug disposition model and identifiability of model parameters
- (2008) Leonid Gibiansky et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now